Biogen Idec Inc is categorized under Commercial Biotechnical Research in Durham, NC .
Biogen Idec Inc was established in 0, and today employs 1 to 4, earning $500.000.000 to $999.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 3254140 by the NAICS.
If you are seeking more information, feel free to contact Carl Ducote, Information Technology at the company’s branch by writing to 5000 Davis Drive, Durham, North Carolina NC 27709 or by phoning (919) 941-1100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biogen Idec Inc |
| Contact Person: | Carl Ducote, Information Technology |
| Address: | 5000 Davis Drive, Durham, North Carolina 27709 |
| Phone Number: | (919) 941-1100 |
| Website Address: | biogenidec.com |
| Annual Revenue (USD): | $500.000.000 to $999.999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 3254140 |
| Share This Business: |
Biogen Idec Inc was started in 0 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 3254140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000.000 to $999.999.999 per annum.
Feel free to contact Carl Ducote, Information Technology for inquiries that concern Biogen Idec Inc by calling the company number (919) 941-1100, as your correspondence is most welcome. Additionally, the physical location of the branch of Biogen Idec Inc can be found at the coordinates 35.89312,-78.86452 as well as the street address 5000 Davis Drive in Durham, North Carolina 27709.
For its online presence, you may visit Biogen Idec Inc’s website at biogenidec.com and engage with its social media outlets through on Twitter and on Facebook.